UPDATE: SunTrust Upgrades Yelp (YELP) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
CRT Capital Upgrades Yelp (YELP) to Buy
April 9, 2014 6:34 AM EDTCRT Capital upgraded Yelp (NYSE: YELP) from Fairly Valued to Buy.
For an analyst ratings summary and ratings history on Yelp click here. For more ratings news on Yelp click here.
Shares of Yelp closed at $67.25 yesterday.
... MoreOppenheimer Upgrades Yelp (YELP) to Outperform
April 7, 2014 7:38 AM EDTOppenheimer upgraded Yelp (NYSE: YELP) from Perform to Outperform.
For an analyst ratings summary and ratings history on Yelp click here. For more ratings news on Yelp click here.
Shares of Yelp closed at $65.76 yesterday.
... MoreUPDATE: Oppenheimer Sees Opportunity in Tech Sell-Off; Netflix (NFLX) and Yelp (YELP) Raised to Outperform
April 7, 2014 7:37 AM EDT(Updated - April 7, 2014 9:30 AM EDT)
Oppenheimer upgraded Netflix (NASDAQ: NFLX) from Perform to Outperform with a price target of $419. Yelp (NASDAQ: YELP) was also upgraded to Outperform with a price target of $78. Analyst Jason Helfstein sees... More
Blood-Bath in Nasdaq Stocks
April 4, 2014 12:37 PM EDTStocks are under heavy mid-day pressure Friday, led by the blood-letting in high-growth, high-multiple momentum names that litter the Nasdaq. The Nasdaq is down 88 points, or 2%, while the Dow and S&P 400 are lower but down just 0.3% and 0.5%, respectively.
The selling that started in the biotech sector a... More
